Editorial
 A DISMAL YEAR FOR PHARMA INVESTORS   
 Wednesday, January 22, 2020 
 The year 2019 was a dismal year for the investors who had invested their hard earned wealth in the pharma and healthcare index in the country’s premier stock exchange, the Sensex. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Wize Pharma completes patient enrollment in phase IV study of LO2A to treat DES in patients with Sjögren's syndrome
17:00  [IST]Quest Diagnostics buys specialty genetic testing company, Blueprint Genetics
16:10  [IST]FOGSI joins hands with Maharashtra Government to improve quality of maternity care in private hospitals
16:00  [IST]KACS to organize one-day workshop on ‘standardization of ayurvedic formulations’ on Jan 24 at Thiruvananthapuram
15:45  [IST]Reproductive health brand Crysta raises Rs.10 crore pre-Series A funding
15:30  [IST]Alembic Pharma gets US FDA approval for generic Latisse ophthalmic solution
more news >>
TOP NEWS
08:00  [IST]DoP in talks with environment ministry to notify environment clearances at state level to boost API parks
08:00  [IST]Hyderabad in Telangana and Vizag in AP to become two major hubs for bulk drug manufacturing in south India
08:00  [IST]DoP rejects Emcure Pharma's review application against NPPA's price notification on emtricitabine+tenofovir tablets
08:00  [IST]DocMode to create value-based online learning experience; to introduce new courses in new specialties
08:00  [IST]CCMB research study reveals genetic alterations in malarial parasite can help control spread of malaria effectively
08:00  [IST]IP Alliance asks govt to clarify on eligibility of existing units on refund scheme under GST for units located in states with tax sops
more news >>
YESTERDAY'S NEWS
18:00  [IST]RegeneRx partner HFHS receives Korean patent for Tß4 composition for reducing diabetic-induced vascular dysfunction
17:30  [IST]No case detected through screening efforts of 9,156 passengers for novel coronavirus: Union health ministry
17:00  [IST]GSK's belantamab mafodotin gets US FDA priority review status to treat relapsed/refractory multiple myeloma
16:10  [IST]Rakesh Jhunjhunwala increases stake in Fortis Healthcare
16:00  [IST]Pharming gets European approval of new facility for expansion of Ruconest production
15:50  [IST]Alembic Pharma Q3 net profit up 38% at Rs.234 crore
more news >>
INTERVIEW  
Med-tech ramps up accurate diagnosis with AI and algorithms
120287Ayelet_Interview Dr Ayelet Akselrod-Ballin, director of AI, Zebra Medical Vision
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
CPhi2020_Banner_150x60px
Gulfood_2020
CPhI_China_150x60_CP
BioAsia_2020
pharma_Proj_150x60
Gandhi_auto_2019_Panel
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |